These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11064309)

  • 1. Implantable cardioverter/defibrillator therapy: the meaning of terms.
    Smith ER
    Can J Cardiol; 2000 Oct; 16(10):1325-6. PubMed ID: 11064309
    [No Abstract]   [Full Text] [Related]  

  • 2. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
    O'Brien BJ; Yee R
    Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
    [No Abstract]   [Full Text] [Related]  

  • 3. Chapter 3. Cost effectiveness of ICD therapy: a review of published evidence.
    O'Brien BJ
    Can J Cardiol; 2000 Oct; 16(10):1307-12. PubMed ID: 11064306
    [No Abstract]   [Full Text] [Related]  

  • 4. Expensive medical technologies and "indication extrapolation": the case of implantable cardioverter-defibrillators.
    Simpson CS; Klein GJ; Hoffmaster B
    Am Heart J; 2000 Sep; 140(3):419-22. PubMed ID: 10966539
    [No Abstract]   [Full Text] [Related]  

  • 5. Downward delegation of implantable cardioverter defibrillator decision-making in a restricted-resource environment: the pitfalls of bedside rationing.
    Simpson CS; Hoffmaster B; Dorian P
    Can J Cardiol; 2005 May; 21(7):595-9. PubMed ID: 15940358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 7. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative heart therapy: Defibrillator is less invasive, called cost-effective.
    Lee J
    Mod Healthc; 2012 Oct; 42(44):12-3. PubMed ID: 23227668
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 2. Guidelines and recommendations for ICD therapy.
    Noorani HZ
    Can J Cardiol; 2000 Oct; 16(10):1303-6. PubMed ID: 11064305
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: The economical challenge in the treatment of chronic heart failure: is primary prophylactic implantable cardioverter defibrillator therapy cost-effective in Europe?
    Cowie MR
    Europace; 2009 Oct; 11(10):1407-8; author reply 1408-10. PubMed ID: 19684038
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of statin therapy on risk of ventricular arrhythmia among patients with coronary artery disease and an implantable cardioverter-defibrillator.
    Chiu JH; Abdelhadi RH; Chung MK; Gurm HS; Marrouche NF; Saliba WI; Natale A; Martin DO
    Am J Cardiol; 2005 Feb; 95(4):490-1. PubMed ID: 15695135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 15. Viewpoint: ICD cost-effectiveness.
    Nicholls M
    Circulation; 2006 Aug; 114(6):f121-2. PubMed ID: 16897841
    [No Abstract]   [Full Text] [Related]  

  • 16. Should we afford implantable cardioverter defibrillator therapy?
    Camm AJ
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):59. PubMed ID: 16265354
    [No Abstract]   [Full Text] [Related]  

  • 17. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sudden death. Implantable defibrillators. Value of the technology and economic impact].
    Jazra C
    J Med Liban; 1999; 47(5):301-3. PubMed ID: 10887533
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expenditure and value for money: the challenge of implantable cardioverter defibrillators.
    Boriani G; Biffi M; Martignani C; Diemberger I; Valzania C; Bertini M; Branzi A
    QJM; 2009 May; 102(5):349-56. PubMed ID: 19276209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.